PMDA drug package insert
サリチル酸メチル「東豊」
PMDA Prescription drug · 東豊薬品株式会社 · package insert Oct 10, 2024
Key facts
| Brand names | サリチル酸メチル「東豊」 |
|---|---|
| Nonproprietary names | サリチル酸メチル |
| Companies | 製造販売元／東豊薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 鎮痛・消炎剤 |
| Therapeutic category codes | 872641 |
| YJ codes | 264170AX1028 |
| Approval numbers | 16000AMZ04260000 |
| Package insert edition | 第2版 |
| Package insert date | Oct 10, 2024 |
| PMDA document key | 480162_264170AX1028_1 |
| PMDA company code | 480162 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: